GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's other long-term assets for the quarter that ended in Mar. 2016 was $5,850 Mil.
GlaxoSmithKline PLC's quarterly other long-term assets increased from Sep. 2015 ($5,176 Mil) to Dec. 2015 ($5,831 Mil) and increased from Dec. 2015 ($5,831 Mil) to Mar. 2016 ($5,850 Mil).
GlaxoSmithKline PLC's annual other long-term assets declined from Dec. 2012 ($5,042 Mil) to Dec. 2013 ($4,867 Mil) but then increased from Dec. 2013 ($4,867 Mil) to Dec. 2014 ($5,357 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
GlaxoSmithKline PLC Annual Data
|Other Long-Term Assets||7,030||7,527||5,120||4,911||5,022||5,396||5,042||4,867||5,357||5,831|
GlaxoSmithKline PLC Quarterly Data
|Other Long-Term Assets||4,867||4,862||4,990||5,073||5,357||5,057||5,056||5,176||5,831||5,850|